Alexander M Lesokhin

Author PubWeight™ 41.10^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Nivolumab plus ipilimumab in advanced melanoma.	N Engl J Med	2013	17.53
2	PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma.	N Engl J Med	2014	10.10
3	Immunologic correlates of the abscopal effect in a patient with melanoma.	N Engl J Med	2012	8.46
4	Cyclophosphamide enhances immunity by modulating the balance of dendritic cell subsets in lymphoid organs.	Blood	2010	1.77
5	OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis.	J Exp Med	2009	1.63
6	Self-antigen-specific CD8+ T cell precursor frequency determines the quality of the antitumor immune response.	J Exp Med	2009	1.47
7	Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype.	J Exp Med	2012	1.32
8	Markers for anti-cytotoxic T-lymphocyte antigen 4 (CTLA-4) therapy in melanoma.	Methods Mol Biol	2014	0.81
9	Harnessing the immune system for cancer therapy.	Curr Opin Oncol	2014	0.81
10	Hiding the road signs that lead to tumor immunity.	J Exp Med	2011	0.80